Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Advances in Radiation Oncology|March 4, 2024
Prospective Evaluation of Automated Contouring for CT-Based Brachytherapy for Gynecologic MalignanciesAbigayle C Kraus, Zohaib Iqbal, Rex A Cardan, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapyHazel B Breitz, Richard E Wendt, Michael S Stabin, et al.Cancer Biotherapy & Radiopharmaceuticals|August 24, 2005
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion proteinAndres Forero-Torres, Sui Shen, Hazel Breitz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancerRonald D Alvarez, Warner K Huh, M B Khazaeli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomasJohann S de Bono, Anthony W Tolcher, Andre Forero, et al.Blood|March 5, 2004
Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphomaAndres Forero, Paul L Weiden, Julie M Vose, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 14, 2026
Determining the Critical Graft-to-recipient Weight Ratio Threshold for Safety in Full-right/Full-left Split Liver Transplantation: A Multicentric Cohort StudyMingzheng Chen, Sui Shen, Zixuan Feng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade gliomaAdam N Mamelak, Steven Rosenfeld, Richard Bucholz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibodyCarol M Richman, Sally J Denardo, Robert T O'Donnell, et al.Journal of Experimental & Clinical Cancer Research : CR|March 11, 2023
CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatmentJun Li, Tao Huang, Jun Hua, et al.Pageof 8